SELLAS Life Sciences Group, Inc. (SLS) income statement
SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.66−1.20 (-8.08%)
Close on Nov 20, 2026Market cap $2.76BP/E –Yield –
SELLAS Life Sciences Group, Inc. financial ratios
See a number that looks wrong?